The Centers for Medicare & Medicaid Services today announced final changes to Medicare Advantage and Part D payment policies for calendar year 2019. CMS anticipates the MA plans and Part D sponsors will see an average revenue increase of 3.4%, excluding an expected 3.1% increase in risk scores. CMS finalized changes to the risk adjustment model for aged and disabled beneficiaries enrolled in MA Part C plans beginning in CY 2019, as required by the 21st Century Cures Act, and additional changes to MA and Part D payment policies for CY 2019. CMS must phase in the new risk adjustment model over four years and will use a 25% to 75% blend of the new and previous risk adjustment model for 2019. In addition, the agency will update the MA risk adjustment models for end-stage renal disease plans in 2019, among other changes. However, CMS will not move forward with the proposed changes to the Part D risk adjustment model. The agency also included several changes to combat opioid overuse. AHA will provide more information on the final changes to members soon.

Headline
As major provisions of the 2024 Centers for Medicare & Medicaid Services Interoperability and Prior Authorization Final Rule take effect on Jan. 1, 2027,…
Headline
A new AHA report warns that access to care is increasingly at risk in rural communities as workforce shortages, financial pressures and policy changes threaten…
Headline
The AHA has released a social media toolkit with sample posts and graphics encouraging people to sign up for 2027 health coverage via the Health Insurance…
Headline
Multiple changes to transparency in coverage requirements for insurers were finalized Oct. 5 by the Departments of the Treasury, Labor, and Health and Human…
Headline
The Centers for Medicare & Medicaid Services Sept. 30 finalized its Global Benchmark for Efficient Drug Pricing Model, also known as the GLOBE Model. The…
Headline
The Centers for Medicare & Medicaid Services will cancel approximately 315,000 enrollments impacting more than 760,000 individuals as part of its anti-…